• Revenue increased by 8% to $64,400,158
• Profit from ordinary activities after tax rose by 1%
• Net profit attributable to members also increased by 1%
• Dividends per share remained unchanged at 4.5 cents
• No changes in control of entities or joint ventures

XRF Scientific Ltd has released its Preliminary Final Report for the period ended 30 June 2026. The report highlights an 8% increase in revenue from ordinary activities to $64,400,158, up from $59,448,334 in the previous corresponding period. Profit from ordinary activities after tax also saw a 1% rise to $10,488,149, and net profit attributable to members increased by the same margin to $10,488,149. Dividends remained unchanged at 4.5 cents per share, with no interim dividends paid. The report also notes that there were no changes in control of entities or joint ventures during the period.

Revenue increased by 8%, profit rose by 1%, and net profit increased by 1% for FY2026

The company expects continued growth in revenue and profitability based on current trends and market conditions.